References
- Erlichman C, Fine S, Wang A, Elhakim T. A randomized trial of fluorouracil and folinic acid in patients with metastatic colorectal cancer. J Clin Oncol 1988; 6: 469–75
- Wadler S, Wiemik P H. Clinical update on the role of fluorouracil and recombinant interferon alpha-2a in the treatment of colorectal cancer. Semin Oncol 1990; 17: 16–21
- Gold P, Freedman S O. Demonstration of tumours-specific antigens in human colonic carcinomata by immunological tolerance and absorption techniques. J Exp Med 1965; 121: 439
- Staab H J., Anderer F A. Growth of human colonic adenocarcinoma and development of serum cea in athymic mice. Br J Cancer 1982; 46: 841–7
- Quayle Q. Ability of CEA blood levels to reflect tumour burden: A study in a human xenograft model. Br J Cancer 1982; 46: 220–7
- Kiyama T, Onda M, Tokunaga A, et al. Changes in serum and tissue carcinoembryonic antigen with growth of human cancer xenograft in nude mice. Jpn J Cancer Res 1990; 81: 58–62
- Begent R, Rustin G JS. Tumour markers: from Carcinoembryonic Antigen to Products of Hybridoma Technology. In Cancer Surveys 1988; 8: 108–21
- Sugarbaker P H., Bloomer W D., Corbett E D., Chaf-fey J T. Carcinoembryonic antigen (cea) monitoring of radiation therapy for colorectal cancer. Am J Roentgenol 1976; 127: 641–4
- Staab H J., Anderer F A., Stumpf E, Hornung A, Fischer R, Kieninger G. Eighty-four potential second-look operations based on sequential carcinoembryonic antigen determinations and clinical investigations in patients with recurrent gastrointestinal cancer. Am J Surg 1985; 149: 198–204
- Allen-Mersh T G., Kemeny N, Niedzweicki D, Shurgot B, Daly J M. Significance of a fall in serum CEA concentration in patients with cytotoxic chemotherapy for disseminated colorectal cancer. Gut 1987; 28: 1625–9
- Carl J. Drug resistance patterns assessed from tumor marker analysis. J Nat Cancer Inst 1989; 21: 1631–9
- Koche W. CorFu collaborative group. 5-Fluoro-Uracil (5-FU) plus interferon alfa-2a (Roferon-a) versus 5-Fluoro-Uracil plus Leoucovorin in metastatic colorectal cancer–a result of a multicentre multinational phase III study. Proc Am Soc Clin Oncol 1993; 12: 193
- WHO Handbook for reporting results for cancer treatment. World Health Organization, Geneva 1979, WHO upset publication no. 48
- Adams G L., Glacken M W. The effects of adverse growth conditions on the shedding of carcinoembryonic antigen from cultured LSI80 colon cancer cells. Cancer Commun 1990; 2: 73–80
- Hareyama M, Imai K, Kubo K, et al. Effects of radiation on the expression of carcinoembryonic antigen of Human gastric adenocarcinoma cells. Cancer 1991; 67: 2269–74
- Guadagni F, Robbins P F., Schlom J, Greiner J W. Regulation of carcinoembryonic antigen expression in different human colorectal tumor cells by interferon-gamma. Cancer Res 1990; 50: 6248–55
- Kiang D T., Greenberg L J., Kennedy B J. Tumor marker kinetics in the monitoring of breast cancer. Cancer, 65: 193–9
- Shinkai T, Nagahiro S, Tominaga K, et al. Serial plasma carcinoembryonic antigen measurement for monitoring patients with advanced lung cancer during chemotherapy. Cancer 1986; 57: 1318–23